Ixabepilone and Cyclophosphamide as Neoadjuvant Therapy in HER-2 Negative Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Ixabepilone|DRUG: Cyclophosphamide
Sponsor: SCRI Development Innovations, LLC
Collaborators: Bristol-Myers Squibb